Hyperlipidemia

ISSN 1662-4009 (online)

An indispensable reference tool endorsed by the European Society for Paediatric Endocrinology

Previous issue | Volume 17 | ESPEYB17 | Next issue

Yearbook of Paediatric Endocrinology 2020

12. Type 2 Diabetes, Metabolic Syndrome and Lipid Metabolism

Previous section
Metabolic Syndrome

Table of contents

ey0017.12-12 | Hyperlipidemia

12.12. GPR146 Deficiency protects against hypercholesterolemia and atherosclerosis

ey0017.12-13 | Hyperlipidemia

12.13. 20-Year Follow-up of statins in children with familial hypercholesterolemia

ey0017.12-14 | Hyperlipidemia

12.14. Statins for children with familial hypercholesterolemia

ey0017.12-15 | Hyperlipidemia

12.15. Inclisiran for the treatment of heterozygous familial hypercholesterolemia

ey0017.12-16 | Hyperlipidemia

12.16. Identification of ALK in thinness

ey0017.12-17 | Hyperlipidemia

12.17. Working 9 to 5, not the way to make an academic living: Observational analysis of manuscript and peer review submissions over time

ESPE Yearbook of Paediatric Endocrinology
ISSN 1662-4009 (Online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more

ESPE Yearbook of Paediatric Endocrinology